Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy

OBJECTIVE: Erythropoietin (Epo) is neuroprotective in animal models of neonatal hypoxic-ischemic encephalopathy. We previously reported a phase I safety and pharmacokinetic study of Epo in neonates. This paper presents the neurodevelopmental follow-up of infants who were enrolled in the phase I clin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pediatr Neurol
Autori principali: Rogers, Elizabeth E., Bonifacio, Sonia L., Glass, Hannah C., Juul, Sandra E., Chang, Taeun, Mayock, Dennis E., Durand, David J., Song, Dongli, Barkovich, Anthony J., Ballard, Roberta A., Wu, Yvonne W.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402201/
https://ncbi.nlm.nih.gov/pubmed/25439577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pediatrneurol.2014.08.010
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi